# Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)

> **NCT01638858** · NA · COMPLETED · sponsor: **University of Luebeck** · enrollment: 25 (actual)

## Conditions studied

- Age-Related Macular Degeneration

## Interventions

- **DRUG:** Lucentis (Ranibizumab)

## Key facts

- **NCT ID:** NCT01638858
- **Lead sponsor:** University of Luebeck
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2014-07
- **Final completion:** —
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01638858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01638858, "Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01638858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*